Records containing: Schizophrenia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2009-03-25Fast Titration of Quetiapine Versus Conventional Titration in the Treatment of Schizophrenia/Schizoaffective Disorder: a Randomised, Parallel Group Open Trial
-
CLINICAL_TRIALS study record update · 2009-03-25A 24-Week, Multi-Centre, Open-Label, Single-Arm, Phase IV Study of the Efficacy and Safety of Seroquel (Quetiapine Fumarate) With Daily Dose 600mg-750mg as Mono-Therapy in the Treatment of Acute Schizophrenic Patients
-
CLINICAL_TRIALS study record update · 2009-03-25An Open, Randomised, Parallel, Three Treatment Groups, Multicentre, Phase IV Study - in Real Life - to Compare the Change in Social Outcome of Quetiapine Fumarate (Seroquel®) Combined With Cognitive Remediation Therapy to Conventional Treatment in Patients With Schizophrenia.
-
CLINICAL_TRIALS study record update · 2009-03-25Comparison of Cognitive Functions of Schizophrenic Patients Treated With Sertindole Versus Risperidone
-
CLINICAL_TRIALS study record update · 2009-03-25A Canadian, Multicenter, Double-Blind, Randomized, Parallel-Group Study of the Safety, Tolerability, and Efficacy of Treatment With Higher Doses of Quetiapine Fumarate (Seroquel®) Greater Than 800 mg/Day in Schizophrenic or Schizoaffective Subjects.
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2009-03-25A 6-Week, Multicenter, Double-Blind, Double-Dummy, Randomized Comparison of the Efficacy and Safety of Sustained-Release Formulation Quetiapine Fumarate (SEROQUEL) and Placebo in the Treatment of Acutely Ill Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2009-03-18Neural Inhibition as a Mechanism of Nicotine Dependence Among Persons With Schizophrenia
-
CLINICAL_TRIALS study record update · 2009-03-16A Double-Blind, Placebo-Controlled, Randomized Study of the Efficacy of Celecoxib as Add-on Therapy to Risperidone Versus Risperidone Alone in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2009-03-13An Exploratory Study on Comparison of Electronic Monitoring and Other Measures of Adherence to Antipsychotic Medication in Outpatients With Schizophrenia or Schizoaffective Disorder
-
CLINICAL_TRIALS study record update · 2009-03-12A Pharmacogenetic Investigation of Antipsychotics in Schizophrenia and Schizophrenia-Like Psychoses
-
CLINICAL_TRIALS study record update · 2009-02-26A Placebo-Controlled Trial of CX516 (Ampakine) Added to Clozapine, Olanzapine or Risperidone in Patients With Schizophrenia
-
CLINICAL_TRIALS study record update · 2009-02-24An Eight Week, Double-Blind, Placebo Controlled, Adjunctive Study of the Primary Effects of the Use of Flexible Doses of Modafinil 50mg to 200mg, on the Negative Symptoms, Cognition, and Excessive Daytime Sleepiness in Schizophrenic Patients
-
CLINICAL_TRIALS study record update · 2009-02-24Risperidone Maintenance Treatment for Relapse Prevention in Schizophrenia
-
CLINICAL_TRIALS study record update · 2009-02-24A Phase 2 6-Week, Double-Blind, Placebo-Controlled, Multicenter Trial Of Varenicline Tartrate (CP-526,555) For Cognitive Impairment In Subjects With Schizophrenia
-
CLINICAL_TRIALS study record update · 2009-02-20Development and Pilot Evaluation of Modified Cognitive Behavioural Therapy for Adolescents With Early Onset Psychosis
-
CLINICAL_TRIALS study record update · 2009-02-19Alterations in mRNA and Protein Expression in Human Peripheral Mononuclear Blood Cells (PMC) of Schizophrenia Patients Treated With Fluvoxamine Augmentation of Antipsychotics: Relationship to Clinical Symptoms and Cognitive Function
-
CLINICAL_TRIALS study record update · 2009-02-18Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia. An Independent, Pragmatic, Multicentre, Parallel-Group, Superiority Trial.
-
CLINICAL_TRIALS study record update · 2009-02-06ClinicalTrials.gov study NCT00838123
-
CLINICAL_TRIALS study record update · 2009-02-05The Effect of Intranasal Administration of Oxytocin on Empathic Abilities of Healthy People and People Who Suffer From Schizophrenia.
-
CLINICAL_TRIALS study record update · 2009-02-04Recovery Group Pilot
-
CLINICAL_TRIALS study record update · 2009-02-04CSP #451 - The Clinical and Economic Impact of Olanzapine in the Treatment of Schizophrenia
-
CLINICAL_TRIALS study record update · 2009-01-27ClinicalTrials.gov study NCT00708396
-
CLINICAL_TRIALS study record update · 2009-01-27Evaluating the Risks of Arrhythmia and Sudden Death Associated With Antipsychotic Drugs by Assessing the T Wave Abnormalities in the Holter Electrocardiogram
-
CLINICAL_TRIALS study record update · 2009-01-27Escitalopram in the Treatment of Patient Suffering From Scizophrenia and Obsessive Compulsive Disorder- an Open Label Study
-
CLINICAL_TRIALS study record update · 2009-01-27Donepezil Double Blind Trial for ECT Memory Disfunction